News Release March 17, 2008 As problems surface, Consumerlab.com and the people's pharmacy ask FDA to disclose differences between generic and original drugs WHITE PLAINS, NEW YORK AND DURHAM, NORTH CAROLINA MARCH 17, 2008 An investigation by ConsumerLab
Pharmacologic treatments used for the components of the metabolic syndrome appear to be insufficient to reduce the risk of developing metabolic syndrome-induced cancers 9
As we age, our stomachs produce less acid, which makes it harder to absorb B12 from food
It is also involved in signaling pathways that impact aging and longevity
A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent
Patients typically target 250 mcg to 500 mcg injected subcutaneously to support tendon recovery and gut inflammation